St. Jude ICD Segment Improves 53% In Q2 Despite Competition From CRT
This article was originally published in The Gray Sheet
Executive Summary
St. Jude's pacing and ICD businesses have not been significantly affected by the recent launch of cardiac resynchronization devices from competitors Medtronic and Guidant